Načítá se...
Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection
Hyperinflammatory response caused by infections such as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) increases organ failure, intensive care unit admission, and mortality. Cytokine storm in patients with Coronavirus Disease 2019 (COVID-19) drives this pattern of poor clinical outcome...
Uloženo v:
| Vydáno v: | Biomed Pharmacother |
|---|---|
| Hlavní autoři: | , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Authors. Published by Elsevier Masson SAS.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7904450/ https://ncbi.nlm.nih.gov/pubmed/33691249 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopha.2021.111437 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|